Experience With Hydroxychloroquine and Azithromycin in the Coronavirus Disease 2019 Pandemic: Implications for QT Interval Monitoring

BACKGROUND: Despite a lack of clinical evidence, hydroxychloroquine and azithromycin are being administered widely to patients with verified or suspected coronavirus disease 2019 (COVID‐19). Both drugs may increase risk of lethal arrhythmias associated with QT interval prolongation. METHODS AND RESU...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramireddy, Archana, Chugh, Harpriya, Reinier, Kyndaron, Ebinger, Joseph, Park, Eunice, Thompson, Michael, Cingolani, Eugenio, Cheng, Susan, Marban, Eduardo, Albert, Christine M., Chugh, Sumeet S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429030/
https://www.ncbi.nlm.nih.gov/pubmed/32463348
http://dx.doi.org/10.1161/JAHA.120.017144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429030/
https://www.ncbi.nlm.nih.gov/pubmed/32463348
http://dx.doi.org/10.1161/JAHA.120.017144

Ejemplares similares